T-cell involvement in sex differences in blood pressure control

Clinical Science

Volumn 130, Issue 10, 2016, Pages 773-783

  Crislip, G Ryan ^a   Sullivan, Jennifer C ^a  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

Author keywords

Angiotensin; Blood pressure regulation; Inflammation; Sex differences; T regulatory cell; Th17 cell

Indexed keywords

ANTIGEN; ANTIHYPERTENSIVE AGENT;

ANTIGEN PRESENTING CELL; BLOOD PRESSURE REGULATION; CELL DEATH; CELL DIFFERENTIATION; EXPERIMENTAL HYPERTENSION; HUMAN; HYPERTENSION; NONHUMAN; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; REVIEW; SEX DIFFERENCE; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; TH17 CELL; ANIMAL; BLOOD PRESSURE; CYTOLOGY; DRUG EFFECTS; PATHOPHYSIOLOGY; PHYSIOLOGY; RISK FACTOR; SEXUAL DEVELOPMENT;

ANIMALS; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; HUMANS; HYPERTENSION; RISK FACTORS; SEX CHARACTERISTICS; T-LYMPHOCYTES;

EID: 84974588067     PISSN: 01435221     EISSN: 14708736     Source Type: Journal    
DOI: 10.1042/CS20150620     Document Type: Review

References (117)

1. Mozaffarian, D., Benjamin, E.J., Go, A.S., Arnett, D.K., Blaha, M.J., Cushman, M., de Ferranti, S., Despres, J.P., Fullerton, H.J., Howard, V.J. et al. (2015) Heart disease and stroke statistics-2015 update: a report from the American Heart Association. Circulation 131, e29-322
2. Cohen, J.D. (2009) Hypertension epidemiology and economic burden: refining risk assessment to lower costs. Manag. Care 18, 51-58
3. Harrison, D.G., Guzik, T.J., Lob, H.E., Madhur, M.S., Marvar, P.J., Thabet, S.R., Vinh, A. and Weyand, C.M. (2011) Inflammation, immunity, and hypertension. Hypertension 57, 132-140
4. Harrison, D.G., Vinh, A., Lob, H. and Madhur, M.S. (2010) Role of the adaptive immune system in hypertension. Curr. Opin. Pharmacol. 10, 203-207
5. Trott, D.W. and Harrison, D.G. (2014) The immune system in hypertension. Adv. Physiol. Educ. 38, 20-24
6. McMaster, W.G., Kirabo, A., Madhur, M.S. and Harrison, D.G. (2015) Inflammation, immunity, and hypertensive end-organ damage. Circ. Res. 116, 1022-1033
7. Zhang, J. and Crowley, S.D. (2015) Role of T lymphocytes in hypertension. Curr. Opin. Pharmacol. 21, 14-19
8. Zimmerman, M.A. and Sullivan, J.C. (2013) Hypertension: what's sex got to do with it? Physiology 28, 234-244
9. Sandberg, K., Ji, H. and Hay, M. (2015) Sex-specific immune modulation of primary hypertension. Cell. Immunol. 294, 95-101
10. Cheng, S., Xanthakis, V., Sullivan, L.M. and Vasan, R.S. (2012) Blood pressure tracking over the adult life course: patterns and correlates in the Framingham Heart Study. Hypertension 60, 1393-1399
11. Hermida, R.C., Ayala, D.E., Mojon, A., Fontao, M.J., Chayan, L. and Fernandez, J.R. (2013) Differences between men and women in ambulatory blood pressure thresholds for diagnosis of hypertension based on cardiovascular outcomes. Chronobiol. Int. 30, 221-232
12. Boggia, J., Thijs, L., Hansen, T.W., Li, Y., Kikuya, M., Bjorklund, K., Richart, T., Ohkubo, T., Jeppesen, J., Torp-Pedersen, C. et al. (2011) Ambulatory blood pressure monitoring in 9357 subjects from 11 populations highlights missed opportunities for cardiovascular prevention in women. Hypertension 57, 397-405
13. Wright, Jr, J.T., Williamson, J.D., Whelton, P.K., Snyder, J.K., Sink, K.M., Rocco, M.V., Reboussin, D.M., Rahman, M., Oparil, S., Lewis, C.E. et al. (2015) A randomized trial of intensive versus standard blood-pressure control. N. Engl. J. Med. 373, 2103-2116
14. James, P.A., Oparil, S., Carter, B.L., Cushman, W.C., Dennison-Himmelfarb, C., Handler, J., Lackland, D.T., LeFevre, M.L., MacKenzie, T.D., Ogedegbe, O. et al. (2014) 2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the eighth joint national committee (JNC 8). JAMA 311, 507-520
15. Gu, Q., Burt, V.L., Paulose-Ram, R. and Dillon, C.F. (2008) Gender differences in hypertension treatment, drug utilization patterns, and blood pressure control among us adults with hypertension: data from the National Health and Nutrition Examination survey. Am. J. Hypertens. 21, 789-798
16. Rodriguez-Iturbe, B., Quiroz, Y., Nava, M., Bonet, L., Chavez, M., Herrera-Acosta, J., Johnson, R.J. and Pons, H.A. (2002) Reduction of renal immune cell infiltration results in blood pressure control in genetically hypertensive rats. Am. J. Physiol. Renal. Physiol. 282, F191-F201
17. De Miguel, C., Das, S., Lund, H. and Mattson, D.L. (2010) T lymphocytes mediate hypertension and kidney damage in dahl salt-sensitive rats. Am. J. Physiol. Regul. Integr Comp. Physiol. 298, R1136-R1142
18. Mattson, D.L., James, L., Berdan, E.A. and Meister, C.J. (2006) Immune suppression attenuates hypertension and renal disease in the Dahl salt-sensitive rat. Hypertension 48, 149-156
19. Tipton, A.J., Baban, B. and Sullivan, J.C. (2012) Female spontaneously hypertensive rats have greater renal anti-inflammatory T lymphocyte infiltration than males. Am. J. Physiol. Regul. Integr. Comp. Physiol. 303, R359-R367
20. Guzik, T.J., Hoch, N.E., Brown, K.A., McCann, L.A., Rahman, A., Dikalov, S., Goronzy, J., Weyand, C. and Harrison, D.G. (2007) Role of the T cell in the genesis of angiotensin II induced hypertension and vascular dysfunction. J. Exp. Med. 204, 2449-2460
21. Crowley, S.D., Song, Y.S., Lin, E.E., Griffiths, R., Kim, H.S. and Ruiz, P. (2010) Lymphocyte responses exacerbate angiotensin II-dependent hypertension. Am. J. Physiol. Regul. Integr. Comp. Physiol. 298, R1089-R1097
22. Mattson, D.L., Lund, H., Guo, C., Rudemiller, N., Geurts, A.M. and Jacob, H. (2013) Genetic mutation of recombination activating gene 1 in Dahl salt-sensitive rats attenuates hypertension and renal damage. Am. J. Physiol. Regul. Integr. Comp. Physiol. 304, R407-R414
23. Rudemiller, N., Lund, H., Jacob, H.J., Geurts, A.M. and Mattson, D.L. (2014) Cd247 modulates blood pressure by altering T-lymphocyte infiltration in the kidney. Hypertension 63, 559-564
24. Vinh, A., Chen, W., Blinder, Y., Weiss, D., Taylor, W.R., Goronzy, J.J., Weyand, C.M., Harrison, D.G. and Guzik, T.J. (2010) Inhibition and genetic ablation of the B7/CD28 T-cell costimulation axis prevents experimental hypertension. Circulation 122, 2529-2537
25. Kirabo, A., Fontana, V., de Faria, A.P., Loperena, R., Galindo, C.L., Wu, J., Bikineyeva, A.T., Dikalov, S., Xiao, L., Chen, W. et al. (2014) DC isoketal-modified proteins activate T cells and promote hypertension. J. Clin. Invest. 124, 4642-4656
26. Ma, F., Feng, J., Zhang, C., Li, Y., Qi, G., Li, H., Wu, Y., Fu, Y., Zhao, Y., Chen, H. et al. (2014) The requirement of CD8+ T cells to initiate and augment acute cardiac inflammatory response to high blood pressure. J. Immunol. 192, 3365-3373
27. Trott, D.W., Thabet, S.R., Kirabo, A., Saleh, M.A., Itani, H., Norlander, A.E., Wu, J., Goldstein, A., Arendshorst, W.J., Madhur, M.S. et al. (2014) Oligoclonal CD8+ T cells play a critical role in the development of hypertension. Hypertension 64, 1108-1115
28. Dong, C. (2008) Th17 cells in development: an updated view of their molecular identity and genetic programming. Nat. Rev. Immunol. 8, 337-348
29. Harrington, L.E., Hatton, R.D., Mangan, P.R., Turner, H., Murphy, T.L., Murphy, K.M. and Weaver, C.T. (2005) Interleukin 17-producing CD4+ effector Tt cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat. Immunol. 6, 1123-1132
30. Ivanov, I.I., McKenzie, B.S., Zhou, L., Tadokoro, C.E., Lepelley, A., Lafaille, J.J., Cua, D.J. and Littman, D.R. (2006) The orphan nuclear receptor rorgammat directs the differentiation program of proinflammatory IL-17+ T helper cells. Cell 126, 1121-1133
31. Raphael, I., Nalawade, S., Eagar, T.N. and Forsthuber, T.G. (2015) T cell subsets and their signature cytokines in autoimmune and inflammatory diseases. Cytokine 74, 5-17
32. Zhang, Y., Gu, W. and Sun, B. (2014) Th1/Th2 cell differentiation and molecular signals. Adv. Exp. Med. Biol. 841, 15-44
33. Korn, T., Oukka, M., Kuchroo, V. and Bettelli, E. (2007) Th17 cells: effector T cells with inflammatory properties. Semin. Immunol. 19, 362-371
34. Maddur, M.S., Miossec, P., Kaveri, S.V. and Bayry, J. (2012) Th17 cells: biology, pathogenesis of autoimmune and inflammatory diseases, and therapeutic strategies. Am. J. Pathol. 181, 8-18
35. Kimura, A. and Kishimoto, T. (2011) Th17 cells in inflammation. Int. Immunopharmacol. 11, 319-322
36. Amador, C.A., Barrientos, V., Pena, J., Herrada, A.A., Gonzalez, M., Valdes, S., Carrasco, L., Alzamora, R., Figueroa, F., Kalergis, A.M. and Michea, L. (2014) Spironolactone decreases doca-salt-induced organ damage by blocking the activation of T helper 17 and the downregulation of regulatory T lymphocytes. Hypertension 63, 797-803
37. Madhur, M.S., Lob, H.E., McCann, L.A., Iwakura, Y., Blinder, Y., Guzik, T.J. and Harrison, D.G. (2010) Interleukin 17 promotes angiotensin II-induced hypertension and vascular dysfunction. Hypertension 55, 500-507
38. Krebs, C.F., Lange, S., Niemann, G., Rosendahl, A., Lehners, A., Meyer-Schwesinger, C., Stahl, R.A., Benndorf, R.A., Velden, J., Paust, H.J. et al. (2014) Deficiency of the interleukin 17/23 axis accelerates renal injury in mice with deoxycorticosterone acetate+angiotensin II-induced hypertension. Hypertension 63, 565-571
39. Vignali, D.A., Collison, L.W. and Workman, C.J. (2008) How regulatory T cells work. Nat. Rev. Immunol. 8, 523-532
40. Campbell, D.J. (2015) Control of regulatory T cell migration, function, and homeostasis. J. Immunol. 195, 2507-2513
41. Viel, E.C., Lemarie, C.A., Benkirane, K., Paradis, P. and Schiffrin, E.L. (2010) Immune regulation and vascular inflammation in genetic hypertension. Am. J. Physiol. Heart Circ. Physiol. 298, H938-H944
42. Kvakan, H., Kleinewietfeld, M., Qadri, F., Park, J.K., Fischer, R., Schwarz, I., Rahn, H.P., Plehm, R., Wellner, M., Elitok, S. et al. (2009) Regulatory T cells ameliorate angiotensin II-induced cardiac damage. Circulation 119, 2904-2912
43. Kanellakis, P., Dinh, T.N., Agrotis, A. and Bobik, A. (2011) CD4(+)CD25(+)Foxp3(+) regulatory T cells suppress cardiac fibrosis in the hypertensive heart. J. Hypertens. 29, 1820-1828
44. Kassan, M., Galan, M., Partyka, M., Trebak, M. and Matrougui, K. (2011) Interleukin-10 released by CD4(+)CD25(+) natural regulatory T cells improves microvascular endothelial function through inhibition of NADPH oxidase activity in hypertensive mice. Arterioscler. Thromb. Vasc. Biol. 31, 2534-2542
45. Matrougui, K., Abd Elmageed, Z., Kassan, M., Choi, S., Nair, D., Gonzalez-Villalobos, R.A., Chentoufi, A.A., Kadowitz, P., Belmadani, S. and Partyka, M. (2011) Natural regulatory T cells control coronary arteriolar endothelial dysfunction in hypertensive mice. Am. J. Pathol. 178, 434-441
46. Barhoumi, T., Kasal, D.A., Li, M.W., Shbat, L., Laurant, P., Neves, M.F., Paradis, P. and Schiffrin, E.L. (2011) T regulatory lymphocytes prevent angiotensin II-induced hypertension and vascular injury. Hypertension 57, 469-476
47. Kasal, D.A., Barhoumi, T., Li, M.W., Yamamoto, N., Zdanovich, E., Rehman, A., Neves, M.F., Laurant, P., Paradis, P. and Schiffrin, E.L. (2012) T regulatory lymphocytes prevent aldosterone-induced vascular injury. Hypertension 59, 324-330
48. Tamosiuniene, R., Tian, W., Dhillon, G., Wang, L., Sung, Y.K., Gera, L., Patterson, A.J., Agrawal, R., Rabinovitch, M., Ambler, K. et al. (2011) Regulatory T cells limit vascular endothelial injury and prevent pulmonary hypertension. Circ. Res. 109, 867-879
49. Hernandez, A.L., Kitz, A., Wu, C., Lowther, D.E., Rodriguez, D.M., Vudattu, N., Deng, S., Herold, K.C., Kuchroo, V.K., Kleinewietfeld, M. and Hafler, D.A. (2015) Sodium chloride inhibits the suppressive function of Foxp3+ regulatory T cells. J. Clin. Invest. 125, 4212-4222
50. Baecher-Allan, C.M., Costantino, C.M., Cvetanovich, G.L., Ashley, C.W., Beriou, G., Dominguez-Villar, M. and Hafler, D.A. (2011) CD2 costimulation reveals defective activity by human CD4+CD25(hi) regulatory cells in patients with multiple sclerosis. J. Immunol. 186, 3317-3326
51. McClymont, S.A., Putnam, A.L., Lee, M.R., Esensten, J.H., Liu, W., Hulme, M.A., Hoffmuller, U., Baron, U., Olek, S., Bluestone, J.A. and Brusko, T.M. (2011) Plasticity of human regulatory T cells in healthy subjects and patients with type 1 diabetes. J. Immunol. 186, 3918-3926
52. Phillips, J.D., Knab, L.M., Blatner, N.R., Haghi, L., DeCamp, M.M., Meyerson, S.L., Heiferman, M.J., Heiferman, J.R., Gounari, F., Bentrem, D.J. and Khazaie, K. (2015) Preferential expansion of pro-inflammatory tregs in human non-small cell lung cancer. Cancer Immunol. Immunother. 64, 1185-1191
53. Voo, K.S., Wang, Y.H., Santori, F.R., Boggiano, C., Arima, K., Bover, L., Hanabuchi, S., Khalili, J., Marinova, E., Zheng, B., Littman, D.R. and Liu, Y.J. (2009) Identification of IL-17-producing Foxp3+ regulatory T cells in humans. Proc. Natl. Acad. Sci. U.S.A. 106, 4793-4798
54. Guery, L. and Hugues, S. (2015) Th17 cell plasticity and functions in cancer immunity. Biomed. Res. Int. 2015, 314620
55. Gagliani, N., Vesely, M.C., Iseppon, A., Brockmann, L., Xu, H., Palm, N.W., de Zoete, M.R., Licona-Limon, P., Paiva, R.S., Ching, T. et al. (2015) Th17 cells transdifferentiate into regulatory T cells during resolution of inflammation. Nature 523, 221-225
56. Obermajer, N., Popp, F.C., Soeder, Y., Haarer, J., Geissler, E.K., Schlitt, H.J. and Dahlke, M.H. (2014) Conversion of Th17 into IL-17a(neg) regulatory T cells: a novel mechanism in prolonged allograft survival promoted by mesenchymal stem cell-supported minimized immunosuppressive therapy. J. Immunol. 193, 4988-4999
57. Youn, J.C., Yu, H.T., Lim, B.J., Koh, M.J., Lee, J., Chang, D.Y., Choi, Y.S., Lee, S.H., Kang, S.M., Jang, Y. et al. (2013) Immunosenescent CD8+ T cells and c-x-c chemokine receptor type 3 chemokines are increased in human hypertension. Hypertension 62, 126-133
58. Herrera, J., Ferrebuz, A., MacGregor, E.G. and Rodriguez-Iturbe, B. (2006) Mycophenolate mofetil treatment improves hypertension in patients with psoriasis and rheumatoid arthritis. J. Am. Soc. Nephrol. 17, S218-S225
59. Liu, Z., Zhao, Y., Wei, F., Ye, L., Lu, F., Zhang, H., Diao, Y., Song, H. and Qi, Z. (2014) Treatment with telmisartan/rosuvastatin combination has a beneficial synergistic effect on ameliorating Th17/Treg functional imbalance in hypertensive patients with carotid atherosclerosis. Atherosclerosis 233, 291-299
60. Freier, E., Weber, C.S., Nowottne, U., Horn, C., Bartels, K., Meyer, S., Hildebrandt, Y., Luetkens, T., Cao, Y., Pabst, C. et al. (2010) Decrease of CD4(+)Foxp3(+) T regulatory cells in the peripheral blood of human subjects undergoing a mental stressor. Psychoneuroendocrinology 35, 663-673
61. Atanackovic, D., Schnee, B., Schuch, G., Faltz, C., Schulze, J., Weber, C.S., Schafhausen, P., Bartels, K., Bokemeyer, C., Brunner-Weinzierl, M.C. and Deter, H.C. (2006) Acute psychological stress alerts the adaptive immune response: stress-induced mobilization of effector t cells. J. Neuroimmunol. 176, 141-152
62. Treiber, F.A., Jackson, R.W., Davis, H., Pollock, J.S., Kapuku, G., Mensah, G.A. and Pollock, D.M. (2000) Racial differences in endothelin-1 at rest and in response to acute stress in adolescent males. Hypertension 35, 722-725
63. Sonmez, A., Kisa, U., Uckaya, G., Eyileten, T., Comert, B., Koc, B., Kocabalkan, F. and Ozata, M. (2001) Effects of losartan treatment on T-cell activities and plasma leptin concentrations in primary hypertension. J. Renin Angiotensin. Aldosterone Syst. 2, 112-116
64. Hautefort, A., Girerd, B., Montani, D., Cohen-Kaminsky, S., Price, L., Lambrecht, B.N., Humbert, M. and Perros, F. (2015) T-helper 17 cell polarization in pulmonary arterial hypertension. Chest 147, 1610-1620
65. Perez-Sepulveda, A., Torres, M.J., Khoury, M. and Illanes, S.E. (2014) Innate immune system and preeclampsia. Front. Immunol. 5, 244
66. Laresgoiti-Servitje, E. (2013) A leading role for the immune system in the pathophysiology of preeclampsia. J. Leukoc. Biol. 94, 247-257
67. Cornelius, D.C., Hogg, J.P., Scott, J., Wallace, K., Herse, F., Moseley, J., Wallukat, G., Dechend, R. and LaMarca, B. (2013) Administration of interleukin-17 soluble receptor c suppresses Th17 cells, oxidative stress, and hypertension in response to placental ischemia during pregnancy. Hypertension 62, 1068-1073
68. Tipton, A.J., Baban, B. and Sullivan, J.C. (2014) Female spontaneously hypertensive rats have a compensatory increase in renal regulatory T cells in response to elevations in blood pressure. Hypertension 64, 557-564
69. Zimmerman, M.A., Baban, B., Tipton, A.J., O'Connor, P.M. and Sullivan, J.C. (2014) Chronic ang II infusion induces sex-specific increases in renal T cells in Sprague Dawley rats. Am. J. Physiol. Renal. Physiol. 308, F706-F712
70. Pettersson, U.S., Walden, T.B., Carlsson, P.O., Jansson, L. and Phillipson, M. (2012) Female mice are protected against high-fat diet induced metabolic syndrome and increase the regulatory T cell population in adipose tissue. PLoS One 7, e46057
71. Wang, Y.M. and Alexander, S.I. (2009) CD8 regulatory T cells: what's old is now new. Immunol. Cell Biol. 87, 192-193
72. Cantor, H., Shen, F.W. and Boyse, E.A. (1976) Separation of helper T cells from suppressor T cells expressing different ly components. Ii. Activation by antigen: After immunization, antigen-specific suppressor and helper activities are mediated by distinct T-cell subclasses. J. Exp. Med. 143, 1382-1390
73. Pollow, D.P., Uhrlaub, J., Romero-Aleshire, M.J., Sandberg, K., Nikolich-Zugich, J., Brooks, H.L. and Hay, M. (2014) Sex differences in T-lymphocyte tissue infiltration and development of angiotensin II hypertension. Hypertension 64, 384-390
74. Ji, H., Zheng, W., Li, X., Liu, J., Wu, X., Zhang, M.A., Umans, J.G., Hay, M., Speth, R.C., Dunn, S.E. and Sandberg, K. (2014) Sex-specific T-cell regulation of angiotensin II-dependent hypertension. Hypertension 64, 573-582
75. Amadori, A., Zamarchi, R., De Silvestro, G., Forza, G., Cavatton, G., Danieli, G.A., Clementi, M. and Chieco-Bianchi, L. (1995) Genetic control of the CD4/CD8 T-cell ratio in humans. Nat. Med. 1, 1279-1283
76. Zhang, M.A., Rego, D., Moshkova, M., Kebir, H., Chruscinski, A., Nguyen, H., Akkermann, R., Stanczyk, F.Z., Prat, A., Steinman, L. and Dunn, S.E. (2012) Peroxisome proliferator-activated receptor (PPAR)alpha and-gamma regulate IFNgamma and IL-17a production by human T cells in a sex-specific way. Proc. Natl. Acad. Sci. U.S.A. 109, 9505-9510
77. Tedeschi, S.K., Bermas, B. and Costenbader, K.H. (2013) Sexual disparities in the incidence and course of SLE and RA. Clin. Immunol. 149, 211-218
78. Ryan, M.J. (2009) The pathophysiology of hypertension in systemic lupus erythematosus. Am. J. Physiol. Regul. Integr. Comp. Physiol. 296, R1258-R1267
79. Yang, J., Chu, Y., Yang, X., Gao, D., Zhu, L., Wan, L. and Li, M. (2009) Th17 and natural Treg cell population dynamics in systemic lupus erythematosus. Arthritis Rheum. 60, 1472-1483
80. Lee, H.Y., Hong, Y.K., Yun, H.J., Kim, Y.M., Kim, J.R. and Yoo, W.H. (2008) Altered frequency and migration capacity of CD4+CD25+ regulatory T cells in systemic lupus erythematosus. Rheumatology 47, 789-794
81. Lai, Z.W., Hanczko, R., Bonilla, E., Caza, T.N., Clair, B., Bartos, A., Miklossy, G., Jimah, J., Doherty, E., Tily, H. et al. (2012) N-acetylcysteine reduces disease activity by blocking mammalian target of rapamycin in T cells from systemic lupus erythematosus patients: a randomized, double-blind, placebo-controlled trial. Arthritis Rheum. 64, 2937-2946
82. Tan, T.C., Fang, H., Magder, L.S. and Petri, M.A. (2012) Differences between male and female systemic lupus erythematosus in a multiethnic population. J. Rheumatol. 39, 759-769
83. Wallace, K., Cornelius, D.C., Scott, J., Heath, J., Moseley, J., Chatman, K. and LaMarca, B. (2014) CD4+ T cells are important mediators of oxidative stress that cause hypertension in response to placental ischemia. Hypertension 64, 1151-1158
84. Cao, X., Wang, L.L. and Luo, X. (2013) Expression of regulatory T and helper T cells in peripheral blood of patients with pregnancy-induced hypertension. Clin. Exp. Obstet. Gynecol. 40, 502-504
85. Cornelius, D.C. and Lamarca, B. (2014) Th17-and IL-17-mediated autoantibodies and placental oxidative stress play a role in the pathophysiology of pre-eclampsia. Minerva Ginecol. 66, 243-249
86. Marvar, P.J., Thabet, S.R., Guzik, T.J., Lob, H.E., McCann, L.A., Weyand, C., Gordon, F.J. and Harrison, D.G. (2010) Central and peripheral mechanisms of T-lymphocyte activation and vascular inflammation produced by angiotensin II-induced hypertension. Circ. Res. 107, 263-270
87. Gustafsson, F. (1997) Hypertensive arteriolar necrosis revisited. Blood Press. 6, 71-77
88. Gardner, D.L. (1963) Arteriolar necrosis and the prenecrotic phase of experimental hypertension. Q. J. Exp. Physiol. Cogn. Med. Sci. 48, 156-163
89. Gardner, D.L. and Brooks, P.W. (1963) Arteriolar necrosis in adrenal-regeneration hypertension: influence of preventive treatment with hydralazine on tissue electrolvtes. Br. J. Exp. Pathol. 44, 31-37
90. Mattson, D.L. (2014) Infiltrating immune cells in the kidney in salt-sensitive hypertension and renal injury. Am. J. Physiol. Renal. Physiol. 307, F499-F508
91. Mori, T., Polichnowski, A., Glocka, P., Kaldunski, M., Ohsaki, Y., Liang, M. and Cowley, Jr, A.W. (2008) High perfusion pressure accelerates renal injury in salt-sensitive hypertension. J. Am. Soc. Nephrol. 19, 1472-1482
92. Matzinger, P. (2002) The danger model: a renewed sense of self. Science 296, 301-305
93. Du, L., Hickey, R.W., Bayir, H., Watkins, S.C., Tyurin, V.A., Guo, F., Kochanek, P.M., Jenkins, L.W., Ren, J., Gibson, G. et al. (2009) Starving neurons show sex difference in autophagy. J. Biol. Chem. 284, 2383-2396
94. Wang, F., He, Q., Sun, Y., Dai, X. and Yang, X.P. (2010) Female adult mouse cardiomyocytes are protected against oxidative stress. Hypertension 55, 1172-1178
95. Metcalfe, P.D. and Meldrum, K.K. (2006) Sex differences and the role of sex steroids in renal injury. J. Urol. 176, 15-21
96. Kher, A., Meldrum, K.K., Wang, M., Tsai, B.M., Pitcher, J.M. and Meldrum, D.R. (2005) Cellular and molecular mechanisms of sex differences in renal ischemia-reperfusion injury. Cardiovasc. Res. 67, 594-603
97. Ling, S., Dai, A., Williams, M.R., Myles, K., Dilley, R.J., Komesaroff, P.A. and Sudhir, K. (2002) Testosterone (t) enhances apoptosis-related damage in human vascular endothelial cells. Endocrinology 143, 1119-1125
98. Verzola, D., Gandolfo, M.T., Salvatore, F., Villaggio, B., Gianiorio, F., Traverso, P., Deferrari, G. and Garibotto, G. (2004) Testosterone promotes apoptotic damage in human renal tubular cells. Kidney Int. 65, 1252-1261
99. Park, K.M., Kim, J.I., Ahn, Y., Bonventre, A.J. and Bonventre, J.V. (2004) Testosterone is responsible for enhanced susceptibility of males to ischemic renal injury. J. Biol. Chem. 279, 52282-52292
100. Camper-Kirby, D., Welch, S., Walker, A., Shiraishi, I., Setchell, K.D., Schaefer, E., Kajstura, J., Anversa, P. and Sussman, M.A. (2001) Myocardial Akt activation and gender: Increased nuclear activity in females versus males. Circ. Res. 88, 1020-1027
101. Patten, R.D., Pourati, I., Aronovitz, M.J., Baur, J., Celestin, F., Chen, X., Michael, A., Haq, S., Nuedling, S., Grohe, C. et al. (2004) 17beta-estradiol reduces cardiomyocyte apoptosis in vivo and in vitro via activation of phospho-inositide-3 kinase/Akt signaling. Circ. Res. 95, 692-699
102. Simoncini, T., Hafezi-Moghadam, A., Brazil, D.P., Ley, K., Chin, W.W. and Liao, J.K. (2000) Interaction of oestrogen receptor with the regulatory subunit of phosphatidylinositol-3-oh kinase. Nature 407, 538-541
103. Mian, M.O., Paradis, P. and Schiffrin, E.L. (2014) Innate immunity in hypertension. Curr. Hypertens. Rep. 16, 413
104. McCarthy, C.G., Goulopoulou, S., Wenceslau, C.F., Spitler, K., Matsumoto, T. and Webb, R.C. (2014) Toll-like receptors and damage-associated molecular patterns: novel links between inflammation and hypertension. Am. J. Physiol. Heart Circ. Physiol. 306, H184-H196
105. Jounai, N., Kobiyama, K., Takeshita, F. and Ishii, K.J. (2012) Recognition of damage-associated molecular patterns related to nucleic acids during inflammation and vaccination. Front. Cell. Infect. Microbiol. 2, 168
106. Lopez-Ruiz, A., Sartori-Valinotti, J., Yanes, L.L., Iliescu, R. and Reckelhoff, J.F. (2008) Sex differences in control of blood pressure: role of oxidative stress in hypertension in females. Am. J. Physiol. Heart Circ. Physiol. 295, H466-H474
107. Takeuchi, O. and Akira, S. (2010) Pattern recognition receptors and inflammation. Cell 140, 805-820
108. Singh, M.V. and Abboud, F.M. (2014) Toll-like receptors and hypertension. Am. J. Physiol. Regul. Integr. Comp. Physiol. 307, R501-R504
109. Tipton, A.J. and Sullivan, J.C. (2014) Sex differences in T cells in hypertension. Clin. Ther. 36, 1882-1900
110. Koupenova, M., Mick, E., Mikhalev, E., Benjamin, E.J., Tanriverdi, K. and Freedman, J.E. (2015) Sex differences in platelet toll-like receptors and their association with cardiovascular risk factors. Arterioscler. Thromb. Vasc. Biol. 35, 1030-1037
111. Sales, M.L., Schreiber, R., Ferreira-Sae, M.C., Fernandes, M.N., Piveta, C., Cipolli, J.A., Calixto, A., Matos-Souza, J.R., Geloneze, B., Franchini, K.G. and Nadruz, Jr, W. (2010) The functional toll-like receptor 4 Asp299Gly polymorphism is associated with lower left ventricular mass in hypertensive women. Clin. Chim. Acta 411, 744-748
112. Marriott, I. and Huet-Hudson, Y.M. (2006) Sexual dimorphism in innate immune responses to infectious organisms. Immunol. Res. 34, 177-192
113. Lin, P.Y., Sun, L., Thibodeaux, S.R., Ludwig, S.M., Vadlamudi, R.K., Hurez, V.J., Bahar, R., Kious, M.J., Livi, C.B., Wall, S.R. et al. (2010) B7-h1-dependent sex-related differences in tumor immunity and immunotherapy responses. J. Immunol. 185, 2747-2753
114. Xiao, L., Kirabo, A., Wu, J., Saleh, M.A., Zhu, L., Wang, F., Takahashi, T., Loperena, R., Foss, J.D., Mernaugh, R.L. et al. (2015) Renal denervation prevents immune cell activation and renal inflammation in angiotensin II-induced hypertension. Circ. Res. 117, 547-57
115. Paharkova-Vatchkova, V., Maldonado, R. and Kovats, S. (2004) Estrogen preferentially promotes the differentiation of CD11c+ CD11b (intermediate) dendritic cells from bone marrow precursors. J. Immunol. 172, 1426-1436
116. Douin-Echinard, V., Laffont, S., Seillet, C., Delpy, L., Krust, A., Chambon, P., Gourdy, P., Arnal, J.F. and Guery, J.C. (2008) Estrogen receptor alpha, but not beta, is required for optimal dendritic cell differentiation and [corrected] CD40-induced cytokine production. J. Immunol. 180, 3661-3669
117. Kovats, S. (2012) Estrogen receptors regulate an inflammatory pathway of dendritic cell differentiation: mechanisms and implications for immunity. Horm. Behav. 62, 254-262